Search alternatives:
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 step » _ step (Expand Search), a step (Expand Search), 2 step (Expand Search)
point decrease » point increase (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 step » _ step (Expand Search), a step (Expand Search), 2 step (Expand Search)
-
19981
-
19982
-
19983
-
19984
-
19985
-
19986
-
19987
-
19988
-
19989
-
19990
-
19991
-
19992
Maximum neutralization activity of bnMAbs in a TZM-bl target cell assay.
Published 2015“…<p>(A) The bnMAbs are ordered from left to right according to decreasing medians of MPN. …”
-
19993
Pre-diabetes is associated with increased risk of heart failure among patients with atrial fibrillation
Published 2022“…</p> <p><strong>Results</strong>: Among 17,943 AF patients (mean age 75.5 years, 47% female), 3,711 (20.7%) had pre-diabetes and 10,127 (56.4%) had diabetes at baseline. …”
-
19994
USP22 lentiviral shRNA vectors.
Published 2024“…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”
-
19995
Antibodies.
Published 2024“…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”
-
19996
qRT-PCR primers.
Published 2024“…<div><p>The Ubiquitin Specific Peptidase 22 (USP22), a component of the Spt-Ada-Gcn5 Acetyltransferase (SAGA) histone modifying complex, is overexpressed in multiple human cancers, but how USP22 impacts tumorigenesis is not clear. …”
-
19997
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random...
Published 2023“…The primary outcome was accessed in the “per protocol” population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization’s (WHO) seven-category ordinal scale by day 28. …”
-
19998
FABP5 expression modulates PPAR-γ activity.
Published 2013“…<p><b>A.</b> FABP5 down regulation significantly decreases PPAR-γ activity in primary NHBE cell cultures. …”
-
19999
-
20000